Zymeworks Inc. Income Statement
ZYME / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Zymeworks Inc. reported $106M in revenue and $81M in net loss for FY2025. Revenue has grown at a 22.2% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $106.0M | $76.3M | $76.0M | $39.0M | $26.7M | $39.0M |
| SG&A Expense | $61.5M | $61.5M | $70.4M | $55.2M | $42.6M | $55.2M |
| R&D Expense | $137.0M | $134.6M | $143.6M | $171.2M | $199.8M | $171.2M |
| Operating Income | -$92.5M | -$137.1M | -$138.1M | -$187.5M | -$215.6M | -$187.5M |
| Income Tax | $1.4M | $6.1M | -$568.0K | $429.0K | -$516.0K | $429.0K |
| Net Income | -$81.1M | -$122.7M | -$118.7M | -$180.6M | -$211.8M | -$180.6M |
| EPS (Basic) | -$1.72 | $1.91 | -$4.11 | -$3.58 | -$4.11 | -$3.58 |
| EPS (Diluted) | -$1.72 | $1.90 | -$4.61 | -$3.58 | -$4.61 | -$3.58 |
| Shares Outstanding | 69.0M | 70.1M | 63.1M | 46.6M | 52.1M | 50.4M |
| Operating Margin | -87.3% | -179.7% | -181.6% | -481.3% | - | - |
| Profit Margin | -76.6% | -160.8% | -156.1% | -463.5% | - | - |